A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

• Main Authors: Affronti ML (Author), Woodring S (Author), Peters KB (Author), Herndon II JE (Author), McSherry F (Author), Healy PN (Author), Desjardins A (Author), Vredenburgh JJ (Author), Friedman HS (Author)
• Format: Book
• Published: Dove Medical Press, 2016-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Mary Lou Affronti,1–3 Sarah Woodring,1,2 Katherine B Peters,1,4 James E Herndon II,5 Frances McSherry,5 Patrick N Healy,5 Annick Desjardins,1,4 James J Vredenburgh,6 Henry S Friedman1,2 1The Preston Robert Tisch Brain Tumor Center at Duke, South Hospital, Duke University Medical C...